What is the current Hepatitis B Test Kit market size?

The Hepatitis B Test Kit market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Hepatitis B Test Kit market?

Key drivers include rising hepatitis B cases, awareness campaigns, and advancements in diagnostic technologies.

What are the major challenges facing the Hepatitis B Test Kit market?

Challenges include high costs, limited accessibility in low-income regions, and stringent regulatory frameworks.

Which regions are leading the Hepatitis B Test Kit market?

North America and Europe are currently leading, due to well-established healthcare systems and high awareness.

Who are the top companies in the Hepatitis B Test Kit market?

Top companies include Roche, Abbott, and Siemens, offering a range of diagnostic solutions.

What future opportunities exist in the Hepatitis B Test Kit market?

Future opportunities include emerging markets, point-of-care testing, and integrated diagnostic platforms.

How is technology impacting the Hepatitis B Test Kit market?

Technology is driving the market with advancements in molecular diagnostics, automation, and data analytics.

What is the current regulatory landscape for the Hepatitis B Test Kit market?

The regulatory landscape is stringent, with FDA and CE markings required for market approval and commercialization.

What is the future outlook for the Hepatitis B Test Kit market?

The future outlook is positive, with growing demand and innovations in diagnostic technologies expected to drive growth.

Hepatitis B Test Kit Trends, Opportunities & Forecast 2033

Hepatitis B Test Kit by Application (Hospital, Clinic, Household), by Types (HBsAg Test, HBsAb Test, HBeAg Test, HBeAb Test, HBcAg Test), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Hepatitis B Test Kit Market Size | CAGR 7.2 Forecast 2033

Hepatitis B Test Kit Trends, Opportunities & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Hepatitis B Test Kit Market Overview

The Hepatitis B Test Kit market refers to the industry that provides diagnostic kits for the detection of Hepatitis B virus. As the Hepatitis B Test Kit market size is expected to grow significantly, understanding the growth outlook, market forecast, and industry expansion is crucial for stakeholders. The scope of this market encompasses various types of test kits, including enzyme-linked immunosorbent assay (ELISA) and nucleic acid testing (NAT), used in hospitals, laboratories, and clinics. According to recent estimates, the current Hepatitis B Test Kit market size is approximately $1.4 billion. The Hepatitis B Test Kit market is anticipated to witness a growth forecast with a compound annual growth rate (CAGR) of 7.5% during the forecast period, driven by macro drivers such as increasing prevalence of Hepatitis B, advancements in diagnostic technologies, and growing demand for early disease detection.

Loading chart…

Key forces shaping the Hepatitis B Test Kit industry include technology shifts towards more accurate and rapid diagnostic tests, regulations such as the increasing need for compliance with international standards, and consumer behavior driven by growing awareness about the importance of early disease detection. The largest region for the Hepatitis B Test Kit market is Asia-Pacific, while the fastest-growing region is expected to be Latin America. Overall, the Hepatitis B Test Kit market is poised for significant growth, driven by the increasing demand for diagnostic tests and the expanding industry expansion of the healthcare sector.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	22.32 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	DiaSorin; JAL Medical and JAL Innovation; Fujirebio; ATTOPLEX; Biopanda Reagents; Grifols; Standard Diagnostics; SD Biosensor; Boditech Med; ACON Laboratories; AccuBioTech; Zhejiang Orient Gene Biotech; InTec; JOYSBIO (Tianjin) Biotechnology; Tianlong; Jiangsu Macro & Micro-Test Med-Tech; Guangzhou Biotron Technology; Bioeasy Biotechnology; Taipu Bioscience; Segments
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Hepatitis B Test Kit market is poised for significant growth, driven by increasing awareness and demand for early disease detection. Understanding the market dynamics is crucial for stakeholders to navigate the competitive landscape and capitalize on emerging opportunities.

Growth Drivers2 items

Increasing prevalence of Hepatitis B infections, particularly in developing regions, is driving the demand for effective and accurate diagnostic solutions, thereby fueling the growth of the Hepatitis B Test Kit market size.

Advancements in technology, such as the development of point-of-care testing and molecular diagnostics, are expanding the growth forecast of the Hepatitis B Test Kit market by enhancing test sensitivity and specificity.

Restraints2 items

High cost of advanced Hepatitis B Test Kits, particularly in resource-constrained settings, is a significant restraint to market growth, limiting access to diagnostic services and impacting the overall growth forecast.

Stringent regulatory requirements and the need for compliance with international standards are posing challenges for manufacturers, especially smaller players, to enter the Hepatitis B Test Kit market.

Opportunities2 items

The growing trend towards point-of-care testing presents opportunities for the development of rapid, user-friendly, and affordable Hepatitis B Test Kits, which can significantly expand the market size and growth forecast.

Increasing public-private partnerships aimed at enhancing healthcare infrastructure and improving access to diagnostic services in underserved regions are creating new avenues for the Hepatitis B Test Kit market to grow.

Challenges2 items

The global supply chain disruptions and fluctuations in raw material prices are affecting the production and distribution of Hepatitis B Test Kits, thereby challenging the growth forecast and market stability.

Ensuring data privacy and security in the context of digital diagnostics and telehealth services is a critical challenge that manufacturers and service providers in the Hepatitis B Test Kit market must address to maintain consumer trust.

Market Segmentation

Loading chart…

The Hepatitis B Test Kit market can be segmented based on Application, which includes diagnosis and screening, blood screening, and vaccine testing. The diagnosis and screening segment holds the largest share of the market, as it is the primary application of Hepatitis B test kits. The blood screening segment is also significant, as it helps prevent the transmission of the virus through blood transfusions. Understanding the Hepatitis B Test Kit segmentation is crucial for market players to develop targeted strategies and products.

The Hepatitis B Test Kit market can also be segmented based on Types, which includes subtypes such as HBsAg test, HBV DNA test, HBeAg test, and anti-HBc test. The HBsAg test is the most commonly used test, as it detects the surface antigen of the virus. The HBV DNA test is also widely used, as it measures the viral load in the blood. Each subtype has its own advantages and disadvantages, and understanding the market taxonomy is essential for developing effective products and marketing strategies.

Hepatitis B Test Kit Segmentation Breakdown10 items

Application

Hospital

Clinic

Household

Types

HBsAg Test

HBsAb Test

HBeAg Test

HBeAb Test

HBcAg Test

Regional Insights

Loading chart…

The Hepatitis B Test Kit market growth is anticipated to vary across regions, with distinct drivers influencing each area. The largest region, Asia Pacific, holds a significant share, driven by high adoption rates, government initiatives, and increasing investments in healthcare infrastructure. In contrast, the fastest-growing region, Latin America, is expected to experience rapid growth due to expanding demographics, improving ecosystem maturity, and rising awareness about Hepatitis B.

In North America, key drivers include established infrastructure, strong policies, and high awareness about Hepatitis B, contributing to a notable share of the Hepatitis B Test Kit market. Europe is driven by mature ecosystems, significant investments, and strict regulations, while the Middle East & Africa region is influenced by growing demand, increasing adoption, and government support for Hepatitis B testing.

The regional forecast indicates that Asia Pacific will continue to dominate the Hepatitis B Test Kit market growth, with a significant share, followed by North America and Europe. Latin America and the Middle East & Africa are expected to experience substantial growth, driven by emerging demographics and improving healthcare infrastructure. Understanding these regional dynamics is crucial for stakeholders to navigate the Hepatitis B Test Kit market effectively.

Competitive Landscape

The Hepatitis B Test Kit market is moderately consolidated, with a mix of global players and local/regional companies driving competition. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Hepatitis B Test Kit competitive landscape is characterized by high competition, with companies focusing on differentiation through technology, service models, and channel strength. Global players are expanding their presence in emerging markets, while local companies are focusing on regional expansion and partnerships.

Companies are adopting various strategies to stay competitive, including M&A, partnerships, product launches, and R&D investments. However, they face challenges such as margin pressure, compliance costs, and commoditization. To differentiate themselves, companies are focusing on technology, service models, and cost advantages. The following companies are notable players in the market:

DiaSorin: regional expansion

Fujirebio: innovation pipeline

ATTOPLEX: OEM tie-ups

Biopanda Reagents: premium pricing

Grifols: vertical integration

Standard Diagnostics: local manufacturing

Key Hepatitis B Test Kit Companies20 items

DiaSorin

JAL Medical and JAL Innovation

Fujirebio

ATTOPLEX

Biopanda Reagents

Grifols

Standard Diagnostics

SD Biosensor

Boditech Med

ACON Laboratories

AccuBioTech

Zhejiang Orient Gene Biotech

InTec

JOYSBIO (Tianjin) Biotechnology

Tianlong

Jiangsu Macro & Micro-Test Med-Tech

Guangzhou Biotron Technology

Bioeasy Biotechnology

Taipu Bioscience

Segments

Market Ecosystem

The Hepatitis B Test Kit ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three stages: upstream, where raw materials and components are sourced; midstream, where OEMs and manufacturers integrate these components into test kits; and downstream, where distributors, channel partners, and service providers deliver these kits to end users. The value chain analysis of this ecosystem reveals how value is created and captured at each stage.

Raw material/component suppliers — provide critical components

OEMs / manufacturers — assemble and test Hepatitis B Test Kits

Technology providers — develop underlying technologies

Distributors / channel partners — deliver kits to healthcare facilities

Service providers / after-sales — offer maintenance and support

End users / buyers — purchase and utilize test kits

Regulators/standards bodies — establish guidelines and approvals

The flow of value within the Hepatitis B Test Kit ecosystem is influenced by various control points, including regulatory approvals and standards set by bodies such as the FDA or WHO. Dependency risks, such as input constraints or changes in standards, can impact the availability and adoption of test kits. Furthermore, switching costs and interoperability requirements can affect the partnerships formed between ecosystem participants. The Hepatitis B Test Kit ecosystem may differ by region due to variations in regulatory frameworks, healthcare infrastructure, and disease prevalence, leading to distinct market dynamics and requirements in different areas.

Recent Industry Insights

The Hepatitis B Test Kit industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between leading diagnostic companies have enhanced the distribution and accessibility of Hepatitis B test kits globally. Notable mergers and acquisitions have also taken place, aiming to expand product portfolios and strengthen market presence. Furthermore, innovative product launches have improved the accuracy and convenience of Hepatitis B testing, catering to the growing demand for point-of-care diagnostics.

Additionally, regulatory changes have emphasized the importance of early diagnosis and treatment, driving the adoption of Hepatitis B test kits. A shift in consumer trends towards preventive healthcare has also contributed to the growth of the Hepatitis B Test Kit market. Funding rounds and expansions have supported research and development efforts, enabling companies to introduce advanced testing solutions and address the evolving needs of the healthcare sector.

Analyst Overview

As the Lead Analyst for the Hepatitis B Test Kit market, my expert view is that the market attractiveness is moderate, driven by increasing awareness and growing demand for early diagnosis. The competitive intensity is high, with several major players competing for market share. The long-term outlook for the Hepatitis B Test Kit market outlook is positive, with opportunities for innovation and expansion into emerging markets.

The innovation landscape is evolving, with a focus on point-of-care testing and molecular diagnostics. However, the demand–supply balance is a key risk factor, as shortages of test kits can impact market growth. Overall, decision-makers should be aware of these factors when navigating the Hepatitis B Test Kit market.

11 items

1. Executive Summary

2. Hepatitis B Test Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Hepatitis B Test Kit Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Hepatitis B Test Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Household

6.2. Global Hepatitis B Test Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. HBsAg Test

6.2.2. HBsAb Test

6.2.3. HBeAg Test

6.2.4. HBeAb Test

6.2.5. HBcAg Test

6.3. Global Hepatitis B Test Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Hepatitis B Test Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Hepatitis B Test Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Hepatitis B Test Kit Market Competition by Key Manufacturers

8.1. Global Hepatitis B Test Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Hepatitis B Test Kit: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. DiaSorin

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. JAL Medical and JAL Innovation

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Fujirebio

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. ATTOPLEX

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Biopanda Reagents

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Grifols

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Standard Diagnostics

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. SD Biosensor

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Boditech Med

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. ACON Laboratories

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. AccuBioTech

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Zhejiang Orient Gene Biotech

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. InTec

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. JOYSBIO (Tianjin) Biotechnology

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Tianlong

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Jiangsu Macro & Micro-Test Med-Tech

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Guangzhou Biotron Technology

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Bioeasy Biotechnology

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Taipu Bioscience

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Segments

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Hepatitis B Test Kit Market

Figure 4: Global Hepatitis B Test Kit Market: Drivers

Figure 5: Global Hepatitis B Test Kit Market: Challenges

Figure 6: Global Hepatitis B Test Kit Market: Trends

Figure 7: Global Hepatitis B Test Kit Market: Opportunity

Figure 8: Global Hepatitis B Test Kit Market: Restraint

Figure 9: Global Hepatitis B Test Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Hepatitis B Test Kit Market Value (USD Million) By Region

Figure 15: Global Hepatitis B Test Kit Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Hepatitis B Test Kit Market Value (USD Million) By Region

Figure 23: Global Hepatitis B Test Kit Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

93 items

Table 1: Market Segmentation Analysis

Table 2: Global Hepatitis B Test Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Hepatitis B Test Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Hepatitis B Test Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Hepatitis B Test Kit Market Value (USD Million) By Region

Table 10: Global Hepatitis B Test Kit Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Hepatitis B Test Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Hepatitis B Test Kit Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Hepatitis B Test Kit Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: DiaSorin Basic Information And Sales Area

Table 31: DiaSorin. Products Portfolio

Table 32: JAL Medical and JAL Innovation Basic Information And Sales Area

Table 33: JAL Medical and JAL Innovation. Products Portfolio

Table 34: Fujirebio Basic Information And Sales Area

Table 35: Fujirebio. Products Portfolio

Table 36: ATTOPLEX Basic Information And Sales Area

Table 37: ATTOPLEX. Products Portfolio

Table 38: Biopanda Reagents Basic Information And Sales Area

Table 39: Biopanda Reagents. Products Portfolio

Table 40: Grifols Basic Information And Sales Area

Table 41: Grifols. Products Portfolio

Table 42: Standard Diagnostics Basic Information And Sales Area

Table 43: Standard Diagnostics. Products Portfolio

Table 44: SD Biosensor Basic Information And Sales Area

Table 45: SD Biosensor. Products Portfolio

Table 46: Boditech Med Basic Information And Sales Area

Table 47: Boditech Med. Products Portfolio

Table 48: ACON Laboratories Basic Information And Sales Area

Table 49: ACON Laboratories. Products Portfolio

Table 50: AccuBioTech Basic Information And Sales Area

Table 51: AccuBioTech. Products Portfolio

Table 52: Zhejiang Orient Gene Biotech Basic Information And Sales Area

Table 53: Zhejiang Orient Gene Biotech. Products Portfolio

Table 54: InTec Basic Information And Sales Area

Table 55: InTec. Products Portfolio

Table 56: JOYSBIO (Tianjin) Biotechnology Basic Information And Sales Area

Table 57: JOYSBIO (Tianjin) Biotechnology. Products Portfolio

Table 58: Tianlong Basic Information And Sales Area

Table 59: Tianlong. Products Portfolio

Table 60: Jiangsu Macro & Micro-Test Med-Tech Basic Information And Sales Area

Table 61: Jiangsu Macro & Micro-Test Med-Tech. Products Portfolio

Table 62: Guangzhou Biotron Technology Basic Information And Sales Area

Table 63: Guangzhou Biotron Technology. Products Portfolio

Table 64: Bioeasy Biotechnology Basic Information And Sales Area

Table 65: Bioeasy Biotechnology. Products Portfolio

Table 66: Taipu Bioscience Basic Information And Sales Area

Table 67: Taipu Bioscience. Products Portfolio

Table 68: Segments Basic Information And Sales Area

Table 69: Segments. Products Portfolio

Table 70: Global Market Value (USD Million) (2025-2032) By Application

Table 71: Global Market Share (%) By Application (2032)

Table 72: Global Market Value (USD Million) (2025-2032) By Types

Table 73: Global Market Share (%) By Types (2032)

Table 74: Global Hepatitis B Test Kit Market Value (USD Million) By Region

Table 75: Global Hepatitis B Test Kit Market Share (%) By Region (2025-2032)

Table 76: North America Market Value (USD Million) (2025-2032) By Country

Table 77: North America Market Value (USD Million) (2025-2032) By Application

Table 78: North America Market Value (USD Million) (2025-2032) By Types

Table 79: Europe Market Value (USD Million) (2025-2032) By Country

Table 80: Europe Market Value (USD Million) (2025-2032) By Application

Table 81: Europe Market Value (USD Million) (2025-2032) By Types

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 85: South America Market Value (USD Million) (2025-2032) By Country

Table 86: South America Market Value (USD Million) (2025-2032) By Application

Table 87: South America Market Value (USD Million) (2025-2032) By Types

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 91: Research Programs/Design For This Report

Table 92: Key Data Information From Secondary Sources

Table 93: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Hepatitis B Test Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	22.32 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	DiaSorin; JAL Medical and JAL Innovation; Fujirebio; ATTOPLEX; Biopanda Reagents; Grifols; Standard Diagnostics; SD Biosensor; Boditech Med; ACON Laboratories; AccuBioTech; Zhejiang Orient Gene Biotech; InTec; JOYSBIO (Tianjin) Biotechnology; Tianlong; Jiangsu Macro & Micro-Test Med-Tech; Guangzhou Biotron Technology; Bioeasy Biotechnology; Taipu Bioscience; Segments
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options